ReviewOncotarget2017
Systematic review and critique of circulating miRNAs as biomarkers of stage I-II non-small cell lung cancer.
Francesca Moretti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
31 papers cite it
this paperpooled itcites it